Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Fractyl Health (GUTS)

Fractyl Health Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GUTS
DateTimeSourceHeadlineSymbolCompany
17/03/202518:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
13/03/202521:19Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:GUTSFractyl Health Inc
13/03/202519:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
04/03/202502:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
04/03/202502:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
04/03/202502:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
04/03/202501:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
03/03/202522:24Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GUTSFractyl Health Inc
03/03/202521:05GlobeNewswire Inc.Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesNASDAQ:GUTSFractyl Health Inc
03/03/202521:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GUTSFractyl Health Inc
24/02/202512:00GlobeNewswire Inc.Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025NASDAQ:GUTSFractyl Health Inc
03/02/202523:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
31/01/202513:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
31/01/202513:01GlobeNewswire Inc.Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025NASDAQ:GUTSFractyl Health Inc
30/01/202521:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GUTSFractyl Health Inc
13/01/202512:00GlobeNewswire Inc.Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 CohortNASDAQ:GUTSFractyl Health Inc
12/12/202412:00GlobeNewswire Inc.Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)NASDAQ:GUTSFractyl Health Inc
09/12/202412:00GlobeNewswire Inc.Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)NASDAQ:GUTSFractyl Health Inc
26/11/202412:00GlobeNewswire Inc.Fractyl Health to Participate in the Upcoming December ConferencesNASDAQ:GUTSFractyl Health Inc
13/11/202423:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GUTSFractyl Health Inc
12/11/202421:05GlobeNewswire Inc.Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:GUTSFractyl Health Inc
04/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
04/11/202421:05GlobeNewswire Inc.Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024NASDAQ:GUTSFractyl Health Inc
04/11/202412:00GlobeNewswire Inc.Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024NASDAQ:GUTSFractyl Health Inc
29/10/202411:00GlobeNewswire Inc.Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024NASDAQ:GUTSFractyl Health Inc
28/10/202411:00GlobeNewswire Inc.Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024NASDAQ:GUTSFractyl Health Inc
24/09/202411:00GlobeNewswire Inc.Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines ConferenceNASDAQ:GUTSFractyl Health Inc
03/09/202411:00GlobeNewswire Inc.Fractyl Health to Participate in Upcoming September Investor ConferencesNASDAQ:GUTSFractyl Health Inc
14/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GUTSFractyl Health Inc
14/08/202420:05GlobeNewswire Inc.Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:GUTSFractyl Health Inc
 Showing the most relevant articles for your search:NASDAQ:GUTS